Skip to Content

Cardiogenetics, Volume 11, Issue 1

2021 March - 5 articles

Cover Story: Cardiac amyloidosis is the result of extracellular deposition of amyloid fibrils throughout the heart. Treatment success mostly depends on early diagnosis for AL amyloidosis, while for ATTR amyloidosis, new investigational agents are being studied that can reduce production of transthyretin protein. This review aimed to investigate the current understanding and new research on cardiac amyloidosis new treatment strategies and their clinical outcome. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (5)

  • Case Report
  • Open Access
1 Citations
4,453 Views
8 Pages

Overlapping Phenotype of Cardiomyopathy in a Patient with Double Mutation: A Case Report

  • Sigita Glaveckaitė,
  • Violeta Mikštienė,
  • Eglė Preikšaitienė,
  • Rimvydas Norvilas,
  • Ramūnas Janavičius and
  • Nomeda Rima Valevičienė

Hypertrophic cardiomyopathy and left ventricular noncompaction commonly occur as separate disorders with distinct clinical and pathoanatomical features. However, these cardiomyopathies may have a similar genetic origin with mutations encoding sarcome...

  • Editorial
  • Open Access
2 Citations
3,520 Views
3 Pages

Genetic Susceptibility to SARS-CoV-2: From the Nehandertal Age to 2020

  • Federica Amodio,
  • Martina Caiazza,
  • Paolo Calabrò and
  • Giuseppe Limongelli

Since late 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated coronavirus disease 2019 (COVID-19) have become a worldwide threat to public health [...]

  • Case Report
  • Open Access
1 Citations
4,750 Views
10 Pages

Three Myocardial Diseases in One Heart: Arrhythmogenic Right Ventricular Cardiomyopathy, Left Ventricular Noncompaction and Myocarditis

  • Yulia Lutokhina,
  • Olga Blagova,
  • Nadezhda Varionchik,
  • Svetlana Alexandrova,
  • Nina Gagarina,
  • Eugenia Kogan,
  • Vsevolod Sedov,
  • Anna Shestak,
  • Elena Zaklyazminskaya and
  • Alexander Nedostup

Purpose: To evaluate the clinical features, laboratory and instrumental tests results and the effectiveness of complex treatment in a patient with multiple etiologies of dilated cardiomyopathy (DCM) with a high risk of sudden cardiac death. Methods:...

  • Communication
  • Open Access
2 Citations
6,781 Views
8 Pages

Cardiac Amyloidosis Therapy: A Systematic Review

  • Franco Iodice,
  • Marco Di Mauro,
  • Marco Giuseppe Migliaccio,
  • Angela Iannuzzi,
  • Roberta Pacileo,
  • Martina Caiazza and
  • Augusto Esposito

Heart involvement in Cardiac Amyloidosis (CA) results in a worsening of the prognosis in almost all patients with both light-chain (AL) and transthyretin amyloidosis (ATTR). The mainstream CA is a restrictive cardiomyopathy with hypertrophic phenotyp...

  • Case Report
  • Open Access
8 Citations
5,250 Views
9 Pages

Mosaic Fabry Disease in a Male Presenting as Hypertrophic Cardiomyopathy

  • Maria Xu,
  • Christopher Orsborne,
  • James Eden,
  • Andrew Wallace,
  • Heather J. Church,
  • Karen Tylee,
  • Sasalu Deepak,
  • Christopher Cassidy,
  • Peter Woolfson and
  • William G. Newman
  • + 3 authors

We describe a 55 year old male diagnosed with cardiomyopathy due to Fabry disease. Biochemical testing of blood spot and plasma showed low-normal alpha-galactosidase A (α-Gal A) levels. Genetic testing revealed somatic mosaicism for GLA c.901C&...

XFacebookLinkedIn
Cardiogenetics - ISSN 2035-8148